USA - engelsk - NLM (National Library of Medicine)

carilion materials management - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 80 mg in 15 ml - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. elixophyllin elixir (theophylline oral solution, usp) is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

mundipharma gesellschaft mit beschränkter haftung - geschäftsanschrift - (3083021) - theophyllin - retardtablette - teil 1 - retardtablette; theophyllin (00323) 200 milligramm

USA - engelsk - NLM (National Library of Medicine)

monarch pharmaceuticals, inc. - theophylline, anhydrous (unii: 0i55128jyk) (theophylline - unii:c137dtr5rg) - tablet - 300 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. quibron® -t accudose® tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

ethypharm - théophylline - gélule - 300 mg - composition pour une gélule > théophylline : 300 mg - derives xanthiques- autres antiasthmatiques par voie systemique

USA - engelsk - NLM (National Library of Medicine)

forest pharmaceuticals, inc. - theophylline, anhydrous (unii: 0i55128jyk) (theophylline, anhydrous - unii:0i55128jyk) - liquid - 80 mg in 15 ml - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. elixophyllin elixir is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

USA - engelsk - NLM (National Library of Medicine)

ax pharmaceutical corp - theophylline (unii: c137dtr5rg) (theophylline anhydrous - unii:0i55128jyk) - theophylline 495 g in 500 g

USA - engelsk - NLM (National Library of Medicine)

ax pharmaceutical corp - theophylline (unii: c137dtr5rg) (theophylline - unii:c137dtr5rg) - theophylline 495 g in 500 g

USA - engelsk - NLM (National Library of Medicine)

ax pharmaceutical corp - theophylline (unii: c137dtr5rg) (theophylline - unii:c137dtr5rg) -

USA - engelsk - NLM (National Library of Medicine)

rhodes pharmaceuticals - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

lavipharm a.e. (0000001220) agias marinas str., peania, attiki, 190 02 - theophylline, theophylline anhydrous - prolonged release tablets - 200mg - theophylline, theophylline anhydrous (0000058559) 200mg - theophylline